autograft

(redirected from autologous graft)
Also found in: Thesaurus, Medical, Legal, Financial, Encyclopedia.
Related to autologous graft: allogeneic graft, autologous tissue

au·to·graft

 (ô′tō-grăft′)
n.
A graft in which the tissue or organ is transplanted within the same individual, usually from one location to another.

au′to·graft′ v.

autograft

(ˈɔːtəˌɡrɑːft)
n
(Surgery) surgery a tissue graft obtained from one part of a patient's body for use on another part

au•to•graft

(ˈɔ təˌgræft, -ˌgrɑft)

n.
a tissue or organ that is grafted into a new position on the body of the individual from whom it was removed. Compare allograft, xenograft.
[1915–20]

autograft

Skin graft using skin from patient receiving the graft. Compare homograft.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.autograft - tissue that is taken from one site and grafted to another site on the same person; "skin from his thigh replaced the burned skin on his arms"
graft, transplant - (surgery) tissue or organ transplanted from a donor to a recipient; in some cases the patient can be both donor and recipient
Translations

au·to·graft

n. autoinjerto, injerto que se transfiere de una parte a otra del cuerpo del mismo paciente.
References in periodicals archive ?
The US market for 'Organ and Tissue Transplantation' in this report is analyzed by the following Product Segments: Organ Type (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine), Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), and Bone Graft Transplantation (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial).
Auricular cartilage grafts may be the most frequently used autologous graft material in facial plastic surgery.
Reviroc(TM) is under development for the elimination of cancer cells from an autologous graft in bone marrow transplantations for end-stage blood cancer patients.
Reviroc is under development for the elimination of cancer cells from an autologous graft in bone marrow transplantation for end-stage blood cancer patients.
Among other activities, the companies will co-fund Genzyme's ongoing Myoblast Autologous Graft in Ischemic Cardiomyopathy (MAGIC) Phase 2 clinical trial of cell therapy to repair damaged heart tissue.

Full browser ?